AI - EDIT SLS among premarket gainers
Immutep (IMMP) +132% after breast cancer trial shows promising survival data.Greenwich LifeSciences (GLSI) +57%.UTStarcom Holdings (UTSI) +50%.Panbela Therapeutics (PBLA) +46%.Leju Holdings (LEJU) +38%.SELLAS Life Sciences (SLS) +36%.ClearOne (CLRO) +35% to expand its footprint in Middle East.ReWalk Robotics (RWLK) +27% as leading German private health insurer enters contract to provide ReWalk exoskeletons to individuals with spinal cord injuries.Silver Spike Acquisition (SSPK) +23%.TG Therapeutics (TGTX) +19% on positive ublituximab data in multiple sclerosis.Editas Medicine (EDIT) +17% on submitting IND application for EDIT-301.Veru (VERU) +17%.Asana (ASAN) +16%. on Q3 results.Academy Sports and Outdoors (ASO) +14% on Q3 earnings.Qutoutiao (QTT) +13%.ObsEva (OBSV) +10% on sustained efficacy and continued safety in treatment of uterine fibroids.Flying Eagle Acquisition (FEAC) +8%.Lee Enterprises (LEE) +11% on Q4 earnings.C3.ai (AI) +7%.Progenity (PROG) +7%.Hoth Therapeutics (HOTH) +6%.Boxlight (BOXL) +6%.China HGS Real Estate (HGSH) +6% on launching the sales center for the Liangzhou Mansion project.Qualigen Therapeutics (QLGN) +8%.Mereo BioPharma (MREO) +6%.
For further details see:
EDIT, SLS among premarket gainers